Description

ADB-FUBINACA

ADB-Fubinaca is known as MAB-FUBINACA, ADBF,but it is NOT ADB-Pinaca. it is a synthetic cannabinoid that has been identified in herbal blends in Janpan. it features a carboxamide group at the 3-indazole position, like STS-135 and SDB-001. ADB-FUBINACA is perfered to be the product of rational drug design

ADB-Fubinaca or MAB-FUBINACA experience(effects)

The enantiomer of it is claimed in Pfizer patent WO 2009/106982 and has been reported to be a a potent agonist of the CB1 receptor and CB2 receptor with a EC50 value of 1.2 nM and 3.5 nM respectively.

ADB-Fubinaca or MAB-FUBINACA review

The physiological and toxicological properties of this compound have not been determined. This product is intended for forensic and research applications.

it is known as MAB-FUBINACA,ADBF,but it is NOT ADB-Pinaca. it is a synthetic cannabinoid that has been identified in herbal blends in Janpan.ADB-FUBINACA features a carboxamide group at the 3-indazole position, like STS-135 and SDB-001. ADB-FUBINACA is perfered to be the product of rational drug design

ADB-Fubinacas or MAB-FUBINACAs experience(effects)

The enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982 and has been reported to be a a potent agonist of the CB1 receptor and CB2 receptor with a EC50 value of 1.2 nM and 3.5 nM respectively.

ADB-Fubinacas or MAB-FUBINACA review

The physiological and toxicological properties of this compound have not been determined. This product is intended for forensic and research applications.

it is known as MAB-FUBINACA, ADBF,but it is NOT ADB-Pinaca. ADB-FUBINACAs is a synthetic cannabinoid that has been identified in herbal blends in Janpan. ADB-FUBINACAs features a carboxamide group at the 3-indazole position, like STS-135 and SDB-001. ADB-FUBINACAs is perfered to be the product of rational drug design

ADB-Fubinacas or MAB-FUBINACA experience(effects)

The enantiomer of it is claimed in Pfizer patent WO 2009/106982 and has been reported to be a a potent agonist of the CB1 receptor and CB2 receptor with a EC50 value of 1.2 nM and 3.5 nM respectively.

ADB-Fubinacas or MAB-FUBINACA review

The physiological and toxicological properties of this compound have not been determined. This product is intended for forensic and research applications.

.                .